Unique First-in-Human Phase I IRB Considerations you Might not Know About
An institutional review board (IRB) may ask some different questions for first-in-human (FIH) Phase I trials than later phase studies.
Our white paper helps address these questions, explaining why:
- Informed consent form (ICF) revisions must be implemented quickly
- IRB experience in Phase I is vital to properly protecting participants
- FIH studies sometimes feature more robust payments and incentives
- House rules are important for everyone’s safety
Download the white paper.
Who Should Watch?
Certificate of Attendance
Time: 1 p.m. ET, 12 p.m. CT, 10 a.m. PT
Duration: 1 hour